Clinical Trials Browser

INDUSTRY × Interventional × Dementia × Clear all

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT06125951 2026-02-18

XanaMIA

Phase 2/3 Active not recruiting

247 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT05637801 2026-02-05

Hope

Phase NA Active not recruiting

670 enrolled

Lymphoid

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05504811 2025-12-24

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

Phase NA Completed

31 enrolled

Lymphoid

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05328115 2025-01-31

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Phase 1 Completed

33 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT06245031 2024-05-07

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Phase NA Enrolling by invitation

402 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT05633095 2023-03-24

The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia

Phase NA Unknown

20 enrolled

Lymphoid

Dementia, Lymphoma, Follicular, Neurocognitive Disorders

NCT03556280 2021-08-24

Overture

Phase NA Active not recruiting

60 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT03661034 2021-08-24

Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

Phase NA Unknown

20 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Memory Disorders, Cognitive Dysfunction

Clinical Trials

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

XanaMIA

Hope

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia

Overture

Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)